Journal of the American College of Cardiology Vol. 37, No. 1, by the American College of Cardiology ISSN /01/$20.
|
|
- Daniela Harrell
- 6 years ago
- Views:
Transcription
1 Journal of the American College of Cardiology Vol. 37, No. 1, by the American College of Cardiology ISSN /01/$20.00 Published by Elsevier Science Inc. PII S (00) Autonomic Dysfunction Ambulatory Norepinephrine Treatment of Severe Autonomic Orthostatic Hypotension Olaf Oldenburg, MD,* Anna Mitchell, MD, Jens Nürnberger, MD, Susanne Koeppen, MD, Raimund Erbel, MD, FACC, FESC,* Thomas Philipp, MD, Andreas Kribben, MD Essen, Germany OBJECTIVES BACKGROUND METHODS RESULTS CONCLUSIONS This study was designed to establish a patient-controlled, ambulatory norepinephrine treatment of refractory orthostatic hypotension due to primary autonomic failure. Autonomic dysfunction leads to disabling postural hypotension. Particularly in primary autonomic dysfunction, repeated syncope and immobilization can be the result. Medical treatment of orthostatic hypotension often fails in advanced cases. Ambulatory, patient-controlled norepinephrine therapy was initiated in six patients with orthostatic hypotension due to primary autonomic failure that had been refractory to conventional treatment. Before this therapy, three patients were bedridden; one was immobilized in a wheelchair. All had recurrent syncope and tolerated upright tilt-table testing for less than 15 min despite extensive medical treatment. For ambulatory treatment, a port-a-cath system was implanted and, using a CADD ambulatory infusion pump, norepinephrine was infused in individually adjusted dosages. Norepinephrine infusion therapy enabled all patients to sit, stay and walk around for more than 45 min. One patient died after a five-year treatment period, another after nine months because of nonhemorrhagic brain stem infarctions, both in the absence of norepinephrine treatment. The remaining four patients are still mobile after a period of 19, 10, 9 and 7 months, respectively. None of them has suffered complications due to arterial hypo- or hypertension, and there has been no infection of the infusion system. In these selected patients with refractory orthostatic hypotension due to primary autonomic dysfunction, ambulatory norepinephrine infusion therapy has proved to be a promising new therapeutic option. Further long-term studies including more patients are necessary to assess additional indications, reliability and safety of this new method. (J Am Coll Cardiol 2001;37: ) 2001 by the American College of Cardiology Patients with severe orthostatic hypotension due to autonomic dysfunction have a severely impaired quality of life. Besides other neurological problems, orthostatic hypotension is one of the leading symptoms and, if advanced, is often refractory to conventional medical treatment. Because of the postural hypotension, recurrent presyncope or syncope, patients are often immobilized. Most adolescent patients with primary autonomic orthostatic hypotension have either Shy-Drager syndrome (multiple system atrophy) or Bradbury-Eggleston syndrome (idiopathic orthostatic hypotension, pure autonomic failure) (1). Despite the limited reliability of plasma catecholamine measurements in the supine and upright positions to establish the autonomic origin of orthostatic hypotension (2), administration of exogenous norepinephrine can maintain an adequate blood pressure (BP) level and can help to avoid orthostatic hypotension (3). Thus, the aim of this study was to establish a new long-term and ambulatory treatment of otherwise refractory cases of orthostatic hypotension. An From the *Division of Internal Medicine, Department of Cardiology, University Hospital, Essen, Germany; Division of Internal Medicine, Department of Nephrology and Hypertension, University Hospital, Essen, Germany; and the Clinic of Neurology, University Hospital, Essen, Germany. Manuscript received May 3, 2000; revised manuscript received August 1, 2000, accepted September 14, ambulatory norepinephrine-infusion system was used to treat orthostatic hypotension in selected patients with Shy- Drager or Bradbury-Eggleston syndrome. METHODS Patients and conventional medical treatment. In six patients with autonomic failure and orthostatic hypotension refractory to conventional therapy, ambulatory patientcontrolled norepinephrine-infusion therapy was studied (Table 1). The diagnoses of autonomic failure and orthostatic hypotension were based on the characteristic medical history, physical and extensive neurological examination, autonomic testing and repeated upright tilt-table tests (4 8). Over a period of at least three months, all patients received nonpharmacological and pharmacological therapy of increasing intensity. Basic therapy consisted of increased fluid and salt intake, elastic stockings, balneotherapy and professional tilt training (5,9,10). Pharmacological treatment started with augmenting dosages of fludrocortisone, directly and indirectly acting sympathomimetics (midodrine, norfenefrine, yohimbine, amezinium) and erythropoietin (11 15). Norepinephrine treatment. The intensive nonpharmacological and pharmacological therapy did not improve ortho-
2 220 Oldenburg et al. JACC Vol. 37, No. 1, 2001 Norepinephrine Treatment of Orthostatic Hypotension January 2001: Abbreviations and Acronyms BP blood pressure HUT hea-up tilt table test MAP mean arterial blood pressure static hypotension and the associated symptoms in these patients (Table 1); three of them were still bedridden, and one patient with Shy-Drager syndrome was still confined to his wheelchair. Therefore, we tested the effects of intravenous infusion of norepinephrine. We administered norepinephrine in increasing individual dosages (5 to 20 ng/kg body weight/min) using a temporary intravenous indwelling catheter and an infusion pump (Original Perfusor Braun, B. Braun Melsungen, Melsungen, Germany). Blood pressure was continuously monitored (Dinamap). The administration of norepinephrine was started in the supine position. After systolic BP had risen about 20 to 30 mm Hg, the patients were allowed to sit up. Then the patients were mobilized, and norepinephrine dosages were adjusted several times during standing and stopped before sitting or lying down. A bolus application on demand was necessary to maintain adequate BP while changing from supine to sitting or from sitting to an upright position. Additionally, it was necessary to work out two different dosages, one for sitting and a higher one for standing position in some patients. Success of the temporary norepinephrine infusion was the requirement for the implantation of a permanent intravenous-infusion system. Permanent norepinephrine infusion. After elucidation about potential hazards of a continuous and self-controlled norepinephrine therapy (e.g., infections, embolization, hypertension and stroke), written informed consent was obtained. A port-a-cath (SIMS Deltec Inc., St. Paul, Minnesota) system was implanted, and every patient was taught to handle an ambulatory infusion pump (CADD, SIMS Deltec Inc., St. Paul, Minnesota). In cooperation with the patients and their relatives and during continuous noninvasive BP monitoring, individual dosages for sitting, standing and walking were established. Individual programming of the infusion pump was necessary to find an optimal treatment regimen. In general, mobilization and ambulation of the patients with Bradbury-Eggleston syndrome was much easier than it was for the patients with accompanying Parkinson symptoms (Shy-Drager syndrome). Before entering an upright or sitting position, the patient had to switch on the system to start the continuous administration of norepinephrine. Additional bolus on demand were given to fill the port-a-cath system and to change from a supine to a sitting or upright position. The pump was switched off or adjusted to a lower infusion rate immediately before sitting or lying down to avoid episodes of severe hypertension in supine or sitting positions. Follow-up. After discharge from the hospital, follow-up visits at least every three months were arranged in our Table 1. Clinical Characteristics of Patients Treated With Norepinephrine Patient Age (yrs) Gender Male Female Female Male Male Female Syndrome Bradbury-Eggleston Bradbury-Eggleston Shy-Drager Shy-Drager Shy-Drager Shy-Drager Without therapy Tilt tolerance 60 head-up (min) Conventional treatment Norepinephrine treatment Walking distance (m) Without therapy Bedridden Bedridden Confined to Bedridden wheelchair Conventional treatment Norepinephrine treatment Unlimited Unlimited Tilt tolerance describes the maximal tolerated time of a 60 head-up tilt-table test before the onset of presyncope or syncope. The limited walking distance during norepinephrine treatment in patients with Shy-Drager syndrome is due to impaired condition, physical strength and coordination problems due to parkinsonism.
3 JACC Vol. 37, No. 1, 2001 January 2001: Oldenburg et al. Norepinephrine Treatment of Orthostatic Hypotension 221 outpatient clinic. During these visits, the history and a full physical examination were obtained, and repeated BP measurements, including 24-h ambulatory measurements, were taken to determine whether the infusion dosage was still optimally adjusted. Special attention was taken to maintain the integrity of the infusion system and to watch for signs of infection. The family physician, a surgeon or an anesthesiologist in cooperation with a local pharmacy replaced drug cassettes, port-needles and infusion systems. Parameters of successful treatment. Success of the therapy was assessed as degree of mobilization, including determination of unimpaired walking distance, 60 upright tilttable tests and 24-h ambulatory BP monitoring. Ethics. Written informed consent was obtained. The local ethics committee approved the study protocol, and all investigations were conducted according to Good Clinical Practice guidelines. RESULTS Symptoms and syncope. Symptoms of orthostatic hypotension, like dizziness, blurred vision, dyspnea and nausea, were noticeably improved in all patients and limited to errors in operating the infusion pump. These consisted of starting the infusion late on the one hand or unnecessary bolus applications with consecutive short hypertensive episodes on the other hand. No syncope occurred during appropriate norepinephrine infusion. Walking distance. During continuous norepinephrine infusion, all patients were mobilized and enabled to walk around unaided. None of the patients was bedridden or confined to a wheelchair anymore. The walking distance in patients with Bradbury-Eggleston syndrome was unlimited, whereas it was finite in patients with Shy-Drager syndrome. Nevertheless, the latter increased their distance about 4 to 25-fold compared with conventional medical treatment. Tilt-table testing. Tilt-table results during patientcontrolled norepinephrine infusion improved markedly compared with the initial testing or combined nonpharmacological and pharmacological (conventional) treatment (Table 1). As an example of successful norepinephrine therapy, Figure 1 shows the tilt-table results of a patient with Shy-Drager syndrome (Patient 4). During conventional treatment, orthostatic hypotension with syncope occurred after 10 min at a mean arterial BP of 50 mm Hg, whereas norepinephrine infusion enabled the patient to tolerate 45 min of tilt-table testing without symptoms. In both cases, heart rate did not change notably. Ambulatory BP measurements. Intermittent and continuous 24-h BP measurements showed markedly reduced episodes of orthostatic hypotension during norepinephrine infusion therapy. Figure 2 shows the example of a patient with Shy-Drager syndrome (Patient 4) in whom recurrent episodes of orthostatic hypotension were successfully treated with the new therapy. In general, supine hypertensive episodes were markedly decreased compared with Figure 1. Changes of MAP during a 60 head-up tilt-table test (HUT) in a patient with Shy-Drager syndrome (Patient 4). Syncope occurred after 10 min during conventional nonpharmacological and pharmacological treatment (lower line), whereas a symptom-free 45 min test was possible with the patient-controlled, ambulatory norepinephrine treatment (upper line). Heart rate remained stationary in both cases. MAP mean arterial blood pressure. conventional treatment, whereas short episodes of hypertension occurred during a delayed turn off while sitting or lying down or if inappropriate bolus applications were given. Long-term follow-up. Ambulatory norepinephrine therapy was successful initially in all six patients in the program. The longest therapy period was five years in a female patient with Shy-Drager syndrome (Patient 6). This patient died at age 75 years because of a nonhemorrhagic brain stem infarction that occurred one morning while she tried to get up without starting the infusion pump. A second non-hemorrhagic stroke was responsible for the death of a 72-year-old patient with Shy-Drager syndrome (Patient 5). In this case, ambulatory infusion therapy was stopped six months earlier. Increasing compliance and coordination problems had led the family physician to stop the norepinephrine treatment. Although conventional therapy had been reintroduced, the patient was confined to his wheelchair again. The other four patients are still being treated successfully and have been mobile for a period of 19, 10, 9 and 7 months, respectively. Infections or embolization have not occurred in any case; hospitalization has been necessary in only one patient (Patient 1) at one-year follow-up. DISCUSSION Autonomic orthostatic hypotension is a rare but severely disabling condition. Impaired autonomic reflexes with inadequate rise of plasma catecholamine levels and an almost fixed heart rate lead to a decrease in BP because of the deficient vasoconstrictor tone and the lack of increase in heart rate (16,17). The upright position is associated with symptoms like blurred vision, light-headedness, dizziness, head and neck discomfort, presyncope or even syncope. Conventional treatment. The conventional approach in treating patients with autonomic orthostatic hypotension consists of a combination of nonpharmacological and pharmacological regimens of increasing intensity (5,9 12,14,15,18,19). Regardless of optimal nonpharmacological or pharmacological treatment, the autonomic insufficiency
4 222 Oldenburg et al. JACC Vol. 37, No. 1, 2001 Norepinephrine Treatment of Orthostatic Hypotension January 2001: Figure 2. Ambulatory blood pressure measurements (MAP) during medical treatment (dashed line) and patient-controlled norepinephrine treatment (solid line) in a patient with Shy-Drager syndrome (Patient 4). The initial drop in MAP at 8:30 h during norepinephrine treatment was due to a delayed start of the infusion pump; the high pressure at 14:50 h was due to an inadvertent additional bolus application. The blood pressure drops at night, especially during conventional treatment, are due to recurrent postural changes during micturition because of urinary incontinence. MAP mean arterial blood pressure. can lead to immobilization and confinement to bed in advanced cases. Another disadvantage of the conventional medical treatment is the development or the worsening of hypertension in patients who remain in the supine position (20). Norepinephrine infusion. Polinsky et al. (3) first used a temporary norepinephrine infusion to overcome orthostatic hypotension during tilt-table testing in two patients with Shy-Drager syndrome. The aim of the current study was to establish an ambulatory and long-term treatment of orthostatic hypotension in cases of severe autonomic failure. We tested the effects of a patient-controlled, ambulatory norepinephrine infusion therapy on BP in supine, sitting and upright positions. In all patients, norepinephrine infusion prevented symptomatic orthostatic hypotension; mobilization was possible in all cases, and some patients were able to walk for the first time in months. Infusion system. The port-a-cath system is a widely used system for intermittent application of different chemotherapeutic agents, mostly in patients with cancer or AIDS. In patients with an impaired immune system, the overall complication rate is 13% to 19%; infections occur in 2% to 5% and occlusions in 3% to 6.5% of all cases (21,22). We have not observed complications related to the implantable venous catheter system. Advantages and limitations. The major advantages of the new therapeutic tool were the ability to mobilize patients previously confined to bed and to avoid syncope. The efficacy has been well-documented in symptom-free head-up tilt-table tests and in increased walking distance. Treatment on demand meant that pre-existing hypertension present in the supine position was not aggravated. The requirement of compliant patients, who can handle the system, is a possible limitation of this new therapeutic approach. Mobilization proved to be much easier in patients without accompanying Parkinson-like neurological symptoms (Bradbury-Eggleston syndrome) than it was for patients with Shy-Drager syndrome. Even this therapeutic approach will not prevent serious complications of the underlying disease in all instances. But although difficulties arose in some cases, an improved quality of life was conveyed to patients with both syndromes. Conclusions. In selected patients with severe and refractory orthostatic hypotension due to autonomic failure, ambulatory and patient-controlled norepinephrine treatment seems to be a promising long-term therapy in compliant patients. However, further studies enrolling larger patient numbers are necessary to establish the role of ambulatory norepinephrine infusion in the treatment of autonomic orthostatic hypotension and to assess additional indications, reliability and safety of this new method. Reprint requests and correspondence: Dr. Olaf Oldenburg, Division of Internal Medicine, Department of Cardiology, University Hospital Essen, Hufelandstrasse #55, D Essen, Germany. olaf.oldenburg@uni-essen.de. REFERENCES 1. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Neurology 1996;46: Meredith IT, Eisenhofer G, Lambert GW, Jennings GL, Thompson J, Esler MD. Plasma norepinephrine responses to head-up tilt are misleading in autonomic failure. Hypertension 1992;19: Polinsky RJ, Samaras GM, Kopin IJ. Sympathetic neural prosthesis for managing orthostatic hypotension. Lancet 1983;1: Mathias CJ. Orthostatic hypotension: causes, mechanisms and influencing factors. Neurology 1995;45:S Grubb BP, Karas B. Clinical disorders of the autonomic nervous system associated with orthostatic intolerance: an overview of classification, clinical evaluation and management. Pacing Clin Electrophysiol 1999;22: Goldstein DS, Holmes C, Cannon RO, III, Eisenhofer G, Kopin IJ.
5 JACC Vol. 37, No. 1, 2001 January 2001: Oldenburg et al. Norepinephrine Treatment of Orthostatic Hypotension 223 Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 1997;336: Philipp T, Distler A, Cordes U. Sympathetic nervous system and blood pressure control in essential hypertension. Lancet 1978;i: Oldenburg O, Sack S, Erbel R, Philipp T, Kribben A. Diagnosis of orthostatic hypotension. Dtsch Med Wochenschr 1999;124: Oldenburg O, Sack S, Erbel R, Philipp T, Kribben A. Treatment of orthostatic hypotension. Dtsch Med Wochenschr 1999;124: Ector H, Reybrouck T, Heidbüchel H, Gewillig M, van de Werf F. Tilt training: a new treatment for recurrent neurocardiogenic syncope and severe orthostatic hypotension. Pacing Clin Electrophysiol 1998; 21: Harada K, Ohmori M, Fujimura A, Ohashi K. Effect of amezinium metilsulfate on the finger vasoconstrictor response to cold stimulation and venoconstrictor response to noradrenaline. Jpn Circ J 1998;62: Hoeldtke RD, Streeten DHP. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993;329: Hussain RM, McIntosh SJ, Lawson J, Kenny RA. Fludrocortisone in the treatment of hypotensive disorders in the elderly. Heart 1996;76: Low PA, Gilden JL, Freeman R, Sheng KN, McElligot MA. Efficacy of midodrine versus placebo in neurogenic orthostatic hypotension. J Am Med Assoc 1997;277: Verwaerde P, Tran MA, Montastruc JL, Senard JM, Portolan G. Effects of yohimbine, an alpha-2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension. Fundam Clin Pharmacol 1997;11: Smith GDP, Watson LP, Mathias CJ. Cardiovascular and catecholamine changes induced by supine exercise and upright exercise and upright posture in vasovagal syncope: comparisons with normal subjects and subjects with sympathetic devervation. Eur Heart J 1996;17: Ziegler M, Lake C, Kopin I. The sympathetic nervous system defect in primary orthostatic hypotension. N Engl J Med 1977;296: Mathias CJ, Kimber JR. Postural hypotension: causes, clinical features, investigation and management. Annu Rev Med 1999;50: Mosqueda-Garcia R, Fernandez-Violante R, Tank J, Snell M, Cummingham G, Furlan R. Yohimbine in neurally mediated syncope. J Clin Invest 1998;102: Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I. The hypertension of autonomic failure and its treatment. Hypertension 1997;30: Kock HJ, Krause U, Pietsch M, Rasfeld S, Walz MK. Implantable catheter systems. Experiences with 1,000 totally implantable venous access systems. Dtsch Med Wochenschr 1996;121: Poorter RL, Lauw FN, Bemelman WA, Bakker PJ, Taat CW, Veenhof CH. Complications of an implantable venous access device (port-a-cath) during intermittent continuous infusion of chemotherapy. Eur J Cancer 1996;32:
ORTHOSTATIC INTOLERANCE AN EXPRESSION OF AUTONOMIC DISFUNCTION IN PARKINSON S DISEASE
Rev. Med. Chir. Soc. Med. Nat., Iaşi 2014 vol. 118, no. 1 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS ORTHOSTATIC INTOLERANCE AN EXPRESSION OF AUTONOMIC DISFUNCTION IN PARKINSON S DISEASE Emilia-Lidia
More information:{ic0fp'16. Geriatric Medicine: Blood Pressure Monitoring in the Elderly. Terrie Ginsberg, DO, FACOI
:{ic0fp'16 ACOFP 53 rd Annual Convention & Scientific Seminars Geriatric Medicine: Blood Pressure Monitoring in the Elderly Terrie Ginsberg, DO, FACOI Blood Pressure Management in the Elderly Terrie B.
More informationSyncope Guidelines: What s New?
Syncope Guidelines: What s New? Dr. Samuel Asirvatham Professor of Medicine and Pediatrics Mayo Clinic College of Medicine Medical Director, Electrophysiology Laboratory Program Director, EP Fellowship
More informationNorthera (droxidopa)
Northera (droxidopa) Policy Number: 5.01.657 Last Review: 07/2018 Origination: 07/2018 Next Review: 07/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for Northera
More informationdroxidopa (Northera )
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationTilt training EM R1 송진우
Tilt training 2006.7.15. EM R1 송진우 Introduction North American Vasovagal Pacemaker Study Randomized, controlled trial Reduction in the likelihood of syncope by dual chamber pacing with rate drop response
More informationDiagnosing and Treating Neurogenic Orthostatic Hypotension: A Case Study
Diagnosing and Treating Neurogenic Orthostatic Hypotension: A Case Study Learning Objectives: Illustrate how to accurately diagnose noh Employ scales and questionnaires in combination with cardiovascular
More informationL-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension
Clin Auton Res (2008) 18[Suppl 1]:19 24 DOI 10.1007/s10286-007-1002-2 ARTICLE Horacio Kaufmann L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension The US experience
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST The Management of Syncope remains a challenge: Clues from the History Richard Sutton, DSc Emeritus Professor of Cardiology Imperial College, St Mary s Hospital, London,
More informationSYNCOPE. Sanjay P. Singh, MD Chairman & Professor, Department of Neurology. Syncope
SYNCOPE Sanjay P. Singh, MD Chairman & Professor, Department of Neurology. Syncope Syncope is a clinical syndrome characterized by transient loss of consciousness (TLOC) and postural tone that is most
More informationContempo GIMSI Cosa cambia alla luce della letteratura in tema di terapia farmacologica
Contempo GIMSI 2015-2017 Cosa cambia alla luce della letteratura in tema di terapia farmacologica Dott.ssa Diana Solari Centro Aritmologico e Sincope Unit, Lavagna www.gimsi.it POST 2 (Prevention of Syncope
More informationExercise Training for PoTS and Syncope
B 140 120 100 80 60 40 20 0 Blood Pressure (mm Hg) Blood Pressure Heart Rate 60 degree Head Up Tilt Time 140 120 100 80 60 40 20 0 Heart Rate (beats.min -1 ) Exercise Training for PoTS and Syncope C Blood
More informationJune 8, 2018, London UK TREATMENT OF VASOVAGAL SYNCOPE
June 8, 2018, London UK TREATMENT OF VASOVAGAL SYNCOPE Where to go for help Syncope: HRS Definition Syncope is defined as: a transient loss of consciousness, associated with an inability to maintain postural
More informationNeurogenic orthostatic hypotension (NOH) results from
Norepinephrine Precursor Therapy in Neurogenic Orthostatic Hypotension Horacio Kaufmann, MD; Daniela Saadia, MD; Andrei Voustianiouk, PhD; David S. Goldstein, MD, PhD; Courtney Holmes, CMT; Melvin D. Yahr,
More informationDesmopressin In The Treatment of Postural Orthostatic Tachycardia
The Journal of Innovations in Cardiac Rhythm Management, 6 (2015), 2222 2226 DOI: 10.19102/icrm. 2015.061202 PHARMACOLOGICAL THERAPY RESEARCH ARTICLE Desmopressin In The Treatment of Postural Orthostatic
More informationOriginal Article Usefulness of Tilt Testing in Children with Syncope: A Survey of Pediatric Electrophysiologists
www.ipej.org 242 Original Article Usefulness of Tilt Testing in Children with Syncope: A Survey of Pediatric Electrophysiologists Anjan S. Batra, MD 1 and Seshadri Balaji, MBBS, MRCP (UK), PhD 2. 1 University
More informationNORTHERA (droxidopa) oral capsule
NORTHERA (droxidopa) oral capsule Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage
More informationPOSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) IT S NOT THAT SIMPLE
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) IT S NOT THAT SIMPLE POTS Irritable heart syndrome. Soldier s heart. Effort syndrome. Vasoregulatory asthenia. Neurocirculatory asthenia. Anxiety neurosis.
More informationOrthostatic Hypotension
Orthostatic Hypotension http://suntechmed.web4.hubspot.com/portals/41365/images/bloodpressuredoctor.jpg Orthostatic (postural) hypotension is an excessive fall in BP when an upright position is assumed.
More informationTreatment of orthostatic hypotension in Multiple System Atrophy New Clinical Studies
Treatment of orthostatic hypotension in Multiple System Atrophy New Clinical Studies Cyndya A. Shibao, M.D., F.A.H.A. Assistant Professor of Medicine Division of Clinical Pharmacology Disclosure Lundbeck
More informationC1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders
C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders GENERAL ISSUES REGARDING MEDICAL FITNESS-FOR-DUTY 1. These medical standards apply to Union Pacific Railroad (UPRR) employees
More informationINTRODUCTION POTS is: Poorly understood Rarely considered SIGNIFICANT morbidity Appropriate initial diagnosis & care will expedite management of POTS
Learning objectives At the end of this presentation the learner should: Define POTS & identify the various etiologies of POTS Be able to differentiate POTS from other causes of orthostatic intolerance
More informationNeurogenic orthostatic hypotension: the very basics
Clin Auton Res (2017) 27:39 43 DOI 10.1007/s10286-017-0437-3 EDITORIAL Neurogenic orthostatic hypotension: the very basics Horacio Kaufmann 1 Jose-Alberto Palma 1 Received: 7 June 2017 / Accepted: 8 June
More informationFaculty Disclosure. Sanjay P. Singh, MD, FAAN. Dr. Singh has listed an affiliation with: Consultant Sun Pharma Speaker s Bureau Lundbeck, Sunovion
Faculty Disclosure Sanjay P. Singh, MD, FAAN Dr. Singh has listed an affiliation with: Consultant Sun Pharma Speaker s Bureau Lundbeck, Sunovion however, no conflict of interest exists for this conference.
More informationHow To Manage Autonomic Symptoms in Multiple System Atrophy. Amanda C. Peltier, MD MS Neurology
How To Manage Autonomic Symptoms in Multiple System Atrophy Amanda C. Peltier, MD MS Neurology Disclosures NIH Autonomic Rare Diseases Consortium Checking your blood pressure several times a day is helpful
More informationPyridostigmine in the Treatment of Postural Orthostatic Tachycardia: A Single-Center Experience
Pyridostigmine in the Treatment of Postural Orthostatic Tachycardia: A Single-Center Experience KHALIL KANJWAL, M.D.,* BEVERLY KARABIN, PH.D.,* MUJEEB SHEIKH, M.D.,* LAWRENCE ELMER, M.D., PH.D., YOUSUF
More informationPostural Orthostatic Tachycardia Syndrome:
Postural Orthostatic Tachycardia Syndrome: A Case Presentation Interesting Cases from the Annals of Women s Heart Care I have no financial relationships or commercial interests to disclose that are relevant
More informationI ngestion of water increases seated blood pressure (BP) in
1737 PAPER The effects of water ingestion on orthostatic hypotension in two groups of chronic autonomic failure: multiple system atrophy and pure autonomic failure T M Young, C J Mathias... See end of
More informationHypotensive susceptibility and antihypertensive drugs Diana Solari Santa Margherita Ligure, 7 aprile 2016
Hypotensive susceptibility and antihypertensive drugs Diana Solari Santa Margherita Ligure, 7 aprile 2016 Arrhythmologic Center, Department of Cardiology, Lavagna SYNCOPE AND ANTIHYPERTENSIVE DRUGS Many
More informationMedical Conditions, Sudden Incapacitation and Assessing Syncope & Unexplained Loss of Consciousness
Medical Conditions, Sudden Incapacitation and Assessing Syncope & Unexplained Loss of Consciousness Kurt T. Hegmann, MD, MPH Professor and Center Director Dr. Paul S. Richards Endowed Chair in Occupational
More informationNeurocardiogenic syncope
Neurocardiogenic syncope Syncope Definition Collapse,Blackout A sudden, transient loss of consciousness and postural tone, with spontaneous recovery Very common Syncope Prevalence All age groups (particularly
More informationL-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension
Clin Auton Res (8) 8[Suppl ]:5 9 DOI.7/s86-7-5-z ARTICLE Christopher J. Mathias L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension The European experience Received: 5 October
More informationSredišnja medicinska knjižnica
Središnja medicinska knjižnica Adamec I., Klepac N., Milivojević I., Radić B., Habek M. (2012) Sick sinus syndrome and orthostatic hypotension in Parkinson's disease. Acta Neurologica Belgica, 112 (3).
More informationSyncope: Evaluation of the Weak and Dizzy
Syncope: Evaluation of the Weak and Dizzy William M. Miles, MD, FACC, FHRS Professor of Medicine Silverstein Chair for Cardiovascular Education University of Florida College of Medicine Disclosures Medtronic,
More informationThe mechanisms that maintain water and electrolyte homeostasis
The Pressor Response to Water Drinking in Humans A Sympathetic Reflex? Jens Jordan, MD; John R. Shannon, MD; Bonnie K. Black, BSN; Yasmine Ali, BS; Mary Farley; Fernando Costa, MD; Andre Diedrich, MD;
More informationClinical Study Nondipping in Parkinson s Disease
SAGE-Hindawi Access to Research Parkinson s Disease Volume 2011, Article ID 897586, 5 pages doi:10.4061/2011/897586 Clinical Study Nondipping in Parkinson s Disease Sita Sommer, 1 Billur Aral-Becher, 1
More informationTilt Table Testing MM /01/2015. HMO; PPO; QUEST Integration 09/22/2017 Section: Medicine Place(s) of Service: Office, Outpatient
Tilt Table Testing Policy Number: Original Effective Date: MM.02.024 01/01/2015 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 09/22/2017 Section: Medicine Place(s) of Service:
More informationTriggering Mechanism for Neurally Mediated Syncope Induced by Head-up Tilt Test Role of Catecholamines and Response to Propranolol
Journal of the American College of Cardiology Vol. 33, No. 2, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(98)00567-1 Triggering
More informationOBJECTIVES BACKGROUND METHODS
Journal of the American College of Cardiology Vol. 34, No. 5, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00365-4 Diagnostic
More informationManaging HTN in the Elderly: How Low to Go
Managing HTN in the Elderly: How Low to Go Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of the Women s Cardiovascular
More informationOrthostatic Hypotension (Postural Hypotension)
Orthostatic Hypotension (Postural Hypotension) Authors: SCIRE Community Team Reviewed by: Darryl Caves, PT Last updated: April 9, 2018 Changes to blood pressure control after spinal cord injury (SCI) may
More informationUse of Methylphenidate in the Treatment of Patients Suffering From Refractory Postural Tachycardia Syndrome
American Journal of Therapeutics 0, 000 000 (2010) Use of Methylphenidate in the Treatment of Patients Suffering From Refractory Postural Tachycardia Syndrome Khalil Kanjwal, MD, 1 Bilal Saeed, MD, 2 Beverly
More informationAutonomic Mediated (Neurocardiogenic) Syncope
Autonomic Mediated (Neurocardiogenic) Syncope Introduction Syncope is brief loss of consciousness causing collapse with spontaneous recovery. Other terms used to describe syncope include blackout, faint,
More informationFindings from the 2015 HRS Expert Consensus Document on Postural Tachycardia Syndrome (POTS) and Inappropriate Sinus Tachycardia (IST)
Findings from the 2015 HRS Expert Consensus Document on Postural Tachycardia Syndrome (POTS) and Inappropriate Sinus Tachycardia (IST) Ahmad Hersi, MBBS, MSc, FRCPC Professor of Cardiac Sciences Consultant
More informationSyncope: Evaluation of the Weak and Dizzy
Syncope: Evaluation of the Weak and Dizzy William M. Miles, MD, FACC, FHRS Professor of Medicine Silverstein Chair for Cardiovascular Education University of Florida College of Medicine Disclosures Medtronic,
More informationMedicine Dr. Aso Lecture 9 Syncope and Pre-syncope
Medicine Dr. Aso Lecture 9 Syncope and Pre-syncope SYNCOPE AND PRE-SYNCOPE Syncope:- sudden, transient loss of consciousness, due to reduced cerebral perfusion. The patient is unresponsive with loss of
More informationVeins. VENOUS RETURN = PRELOAD = End Diastolic Volume= Blood returning to heart per cardiac cycle (EDV) or per minute (Venous Return)
Veins Venous system transports blood back to heart (VENOUS RETURN) Capillaries drain into venules Venules converge to form small veins that exit organs Smaller veins merge to form larger vessels Veins
More informationEffectiveness of Fludrocortisone and Salt in Preventing Syncope Recurrence in Children A Double-Blind, Placebo-Controlled, Randomized Trial
Journal of the American College of Cardiology Vol. 45, No. 4, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.11.033
More informationSyncope Update Dr Matthew Lovell, Consultant in Cardiology
Syncope Update Dr Matthew Lovell, Consultant in Cardiology Definition of Syncope Syncope is defined as TLOC due to cerebral hypoperfusion Characterized by a rapid onset, short duration, and spontaneous
More informationDepartment of Paediatrics Clinical Guideline. Syncope Guideline
Department of Paediatrics Clinical Guideline Syncope Guideline Definition Transient, self-limited loss of consciousness (TLOC), usually leading to falling. Onset is relatively rapid. Recovery is spontaneous,
More informationClinical Studies 129
Clinical Studies 129 Syncope in migraine. The population-based CAMERA study Roland D. Thijs, 1* Mark C. Kruit, 2* Mark A. van Buchem, 2 Michel D. Ferrari, 1 Lenore J. Launer, 3,4 and J. Gert van Dijk
More informationNeurocirculatory Abnormalities in Chronic Orthostatic Intolerance
Neurocirculatory Abnormalities in Chronic Orthostatic Intolerance David S. Goldstein, MD, PhD; Basil Eldadah, MD, PhD; Courtney Holmes, CMT; Sandra Pechnik, RN; Jeffrey Moak, MD; Yehonatan Sharabi, MD
More informationMultiple System Atrophy
Multiple System Atrophy This document has been prepared to help you become more informed about Multiple System Atrophy. It is designed to answer questions about the condition and includes suggestions on
More informationEfficacy of tilt training in the treatment of neurally mediated syncope. A randomized study
Europace (2004) 6, 199e204 Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study Giovanni Foglia-Manzillo a, ), Franco Giada b, Germano Gaggioli c, Angelo Bartoletti
More informationTilt Table Testing. Dr. Prateek Suri
Tilt Table Testing Dr. Prateek Suri Background Syncope is very commonly seen in the population Among the various causes of syncope vasovagal syncope is the most common cause There is an absence of a gold
More informationIl massaggio del seno carotideo Roberto Maggi Centro Aritmologico e Syncope Unit Lavagna, Italia
Il massaggio del seno carotideo Roberto Maggi Centro Aritmologico e Syncope Unit Lavagna, Italia Tigullio Cardiologia, 7 aprile 2016 Carotid sinus hypersensitivity Vagus nerve Glossopharyngeal nerve Carotid
More informationCase Report Treatment of Refractory Postural Tachycardia Syndrome with Subcutaneous Octreotide Delivered Using an Insulin Pump
Case Reports in Medicine Volume 2015, Article ID 545029, 4 pages http://dx.doi.org/10.1155/2015/545029 Case Report Treatment of Refractory Postural Tachycardia Syndrome with Subcutaneous Octreotide Delivered
More informationTreatment of Postural Orthostatic Tachycardia Syndrome and Inappropriate Sinus Tachycardia
Treatment of Postural Orthostatic Tachycardia Syndrome and Inappropriate Sinus Tachycardia M. Yousuf Kanjwal, MD*, Daniel J. Kosinski, MD, and Blair P. Grubb, MD Address *Medical College of Ohio, Room
More informationPHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker
PACKAGE INSERT Pr PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker ACTIONS AND CLINICAL PHARMACOLOGY Phentolamine produces an alpha-adrenergic
More informationIncidence, Clinical Presentation. and Outcome in Patients with Long. Asystole Induced by Head-up Tilt Test
2005 16 134-138 Incidence, Clinical Presentation and Outcome in Patients with Long Asystole Induced by Head-up Tilt Test Ming-Ting Chou, Chen-Chuan Cheng, Wen-Shiann Wu, and Tseui-Yuen Huang Division of
More informationCIC Edizioni Internazionali
Comparison of active standing test, head-up tilt test and 24-h ambulatory heart rate and blood pressure monitoring in diagnosing postural tachycardia Mojca Kirbiš, MD a,b Anton Grad, MD, PhD c Bernard
More informationExercise hemodynamics in Parkinson s Disease and autonomic dysfunction
Exercise hemodynamics in Parkinson s Disease and autonomic dysfunction David A. Low 1,2,3*, Ekawat Vichayanrat 2,3, Valeria Iodice 2,3 and Christopher J. Mathias 2,3 1 Research Institute of Sport and Exercise
More informationRecurrent neurocardiogenic syncope, Tilt training program
Tilt Training for Recurrent Neurocardiogenic Syncope Effectiveness, Patient Compliance, and Scheduling the Frequency of Training Sessions Ozan KINAY, 1 MD, Mehmet YAZICI, 3 MD, Cem NAZLI, 1 MD, Gurkan
More informationOrthostatic Hypotension in the Elderly: Diagnosis and Treatment
The American Journal of Medicine (2007) 120, 841-847 OFFICE MANAGEMENT: GERIATRICS Michael W. Rich, MD, Speciality Editor Orthostatic Hypotension in the Elderly: Diagnosis and Treatment Vishal Gupta, MD,
More informationDifficult Diagnosis: An Interactive Session
Difficult Diagnosis: An Interactive Session W A D E S M I T H, M. D. D E P T. O F N E U R O L O G Y, U C S F F E B R U A R Y 1 5, 2 0 1 3 58-year-old man with HTN and HLD Recurrent episodes of dizziness
More informationKey words: Arrhythmias, Orthostatic Hypotension, Artificial Pacemaker, Syncope, Bradycardia.
JOURNAL OF CASE REPORTS 2013;3(2):353-357 Effective Pacing Therapy for Syncope with Severe Orthostatic Hypotension and Chronotropic Incompetence Tadashi Hashida, Koichiro Yoshioka 1, Yuji Ikari 1 From
More informationManagement Of Medical Emergencies
Management Of Medical Emergencies U.S. Aging Population 35 million people (12%) 65 years or older Number will increase by nearly 75% by year 2030 The number of people more than 85 years old will approach
More informationCardiology Services Bon Secours Hospital. Mary Buckley Staff Nurse Cardiology
Cardiology Services Bon Secours Hospital Mary Buckley Staff Nurse Cardiology Overview Philosophy Cardiology Team Referral Criteria Electrocardiograph (ECG) 24/48 Hour Holter Monitor Event Monitors 24 Hour
More informationHypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to
Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to 90 mmhg. These pressures are called Normal blood pressure
More informationTotally implantable venous access system (TIVAS) Complicated by Tracheo-Venous Fistula
Totally implantable venous access system (TIVAS) Complicated by Tracheo-Venous Fistula Samer Khaled, M.D., Vladimir Gotlieb, M.D., and Arunbai Patel, M.D. Citation: Khaled S, Gotlieb V, Patel A. Totally
More informationSyncope Guidelines Update. Bernard Harbieh, FHRS AUBMC-KMC Beirut-Lebanon
Syncope Guidelines Update Bernard Harbieh, FHRS AUBMC-KMC Beirut-Lebanon New Syncope Guidelines Increase the volume of information on diagnosis and management Incorporation of emergency specialists, neurologists,
More informationWhat are you trying to achieve? Falls Prevention, Assessment and Management Strategies. Falls can be classified into four main groups:
What are you trying to achieve? Falls Prevention, Assessment and Management Strategies Dr Adam Darowski Community: Falls risk assessment: Falls risk is 50% per year in 80yr population and higher in those
More informationNorthera (droxidopa) Preliminary Findings From Study 301 in Symptomatic Neurogenic Orthostatic Hypotension. September 2010
Northera (droxidopa) Preliminary Findings From Study 301 in Symptomatic Neurogenic Orthostatic Hypotension September 2010 1 2004-2010 Chelsea Therapeutics, Inc. This presentation is being provided for
More informationSyncope: Causes and Treatment
March 01, 2006 By Avery Hayes, MD [1] and Mahendr S. Kochar, MD, MS [2] Because the causes of syncope are numerous and the diagnostic tests have low yield, this disorder is often difficult to evaluate.
More informationLONG-TERM FOLLOW-UP OF DDDR CLOSED-LOOP PACING FOR RECURRENT VASO-VAGAL SYNCOPE
LONG-TERM FOLLOW-UP OF DDDR CLOSED-LOOP PACING FOR RECURRENT VASO-VAGAL SYNCOPE M. Bortnik, G. Dell'era, E. Occhetta, L. Plebani, P. Marino University of Eastern Piedmont, Department of Cardiology, Novara,
More informationEvidence-based treatment of neurogenic orthostatic hypotension and related symptoms
J Neural Transm (2017) 124:1567 1605 DOI 10.1007/s00702-017-1791-y HIGH IMPACT REVIEW IN NEUROSCIENCE, NEUROLOGY OR PSYCHIATRY - REVIEW ARTICLE Evidence-based treatment of neurogenic orthostatic hypotension
More informationVanderbilt Autonomic Dysfunction Center Medical Questionnaire
Vanderbilt Autonomic Dysfunction Center Medical Questionnaire Date 1. Contact Information Name: Age: Date of birth: Sex: female male Home Address: City: State Zip Home phone: Cell phone: Email address:
More informationTreatment of Dysautonomia in the Joint Hypermobility Syndrome
Treatment of Dysautonomia in the Joint Hypermobility Syndrome Jaime F. Bravo, MD San Juan de Dios Hospital, Rheumatology Dept. University of Chile Medical School. Santiago, Chile Causes of Dysautonomia
More informationSistema Nervoso Vegetativo Vademecum per la diagnosi differenziale
Sistema Nervoso Vegetativo Vademecum per la diagnosi differenziale Pietro Cortelli IRCCS Istituto delle Scienze Neurologiche di Bologna DIBINEM, Alma Mater Studiorum - Università di Bologna Anatomo-Functional
More informationThe New England Journal of Medicine SYMPATHETIC CARDIONEUROPATHY IN DYSAUTONOMIAS
SYMPATHETIC CARDIONEUROPATHY IN DYSAUTONOMIAS DAVID S. GOLDSTEIN, M.D., PH.D., COURTNEY HOLMES, C.M.T., RICHARD O. CANNON III, M.D., GRAEME EISENHOFER, PH.D., AND IRWIN J. KOPIN, M.D. ABSTRACT Background
More informationResponses to Changes in Posture QUESTIONS. Case PHYSIOLOGY CASES AND PROBLEMS
64 PHYSIOLOGY CASES AND PROBLEMS Case 12 Responses to Changes in Posture Joslin Chambers is a 27-year-old assistant manager at a discount department store. One morning, she awakened from a deep sleep and
More informationRepeated tilt testing in patients with tilt-positive neurally mediated syncope
Europace (25) 7, 628e633 Repeated tilt testing in patients with tilt-positive neurally mediated syncope Hugo Ector a, *, Rik Willems a, Hein Heidbüchel a, Tony Reybrouck b,c a Department of Cardiology,
More informationSubclinical AF: Implications of device based episodes
Subclinical AF: Implications of device based episodes Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Clinical Trials and Consulting: Medtronic, Boston Scientific
More informationCardiac Pathophysiology
Cardiac Pathophysiology Evaluation Components Medical history Physical examination Routine laboratory tests Optional tests Medical History Duration and classification of hypertension. Patient history of
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Northera) Reference Number: CP.PMN.17 Effective Date: 08.01.16 Last Review Date: 11.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy
More informationCHANGING THE WAY HEART FAILURE IS TREATED. VAD Therapy
CHANGING THE WAY HEART FAILURE IS TREATED VAD Therapy VAD THERAPY IS BECOMING AN ESSENTIAL PART OF HEART FAILURE PROGRAMS AROUND THE WORLD. Patients with advanced heart failure experience an impaired quality
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationSyncope and Cardiovascular Causes of Falls in Older People. Professor T. Masud Nottingham University Hospitals NHS Trust
Syncope and Cardiovascular Causes of Falls in Older People Professor T. Masud Nottingham University Hospitals NHS Trust Faller 1 75 male, smoker, moderate alcohol intake Retired driving instructor At least
More informationNeurocardiogenic Syncope and Related Disorders of Orthostatic Intolerance Blair P. Grubb DOI: /CIRCULATIONAHA
Neurocardiogenic Syncope and Related Disorders of Orthostatic Intolerance Blair P. Grubb Circulation 2005;111;2997-3006 DOI: 10.1161/CIRCULATIONAHA.104.482018 Circulation is published by the American Heart
More informationProlonged Asystole during Head-Up Tilt Test in a Patient with Malignant Neurocardiogenic Syncope
Case Report Prolonged Asystole during Head-Up Tilt Test in a Patient with Malignant Neurocardiogenic Syncope Takashi Tokano MD 1, Yuji Nakazato MD 2, Akitoshi Sasaki MD 3, Gaku Sekita MD 3, Masayuki Yasuda
More informationMultiple choice questions: ANSWERS
Multiple choice questions: ANSWERS Chapter 1. Redefining Parkinson s disease 1. Common non-motor features that precede the motor findings in Parkinson s disease (PD) include all of the following except?
More informationIndex. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Adenosine in idiopathic AV block, 445 446 Adolescent(s) syncope in, 397 409. See also Syncope, in children and adolescents AECG monitoring.
More informationEvaluation of Dizziness and Fainting in Children and Adolescents
Evaluation of Dizziness and Fainting in Children and Adolescents Collin Cowley, MD - Pediatric Cardiology Lynne Kerr, MD, PhD Pediatric Neurology Chuck Norlin, MD General Pediatrics Bettina Smith Edmondson,
More informationManagement of syncope in 2014 Role of tilt test
Gdansk BEATA Symposium October 10-11, 2014 Management of syncope in 2014 Role of tilt test Antonio Raviele, MD, FESC, FHRS ALFA Alliance to Fight Atrial fibrillation, Mestre Venice, Italy Protocols /
More informationSHOCK AETIOLOGY OF SHOCK (1) Inadequate circulating blood volume ) Loss of Autonomic control of the vasculature (3) Impaired cardiac function
SHOCK Shock is a condition in which the metabolic needs of the body are not met because of an inadequate cardiac output. If tissue perfusion can be restored in an expeditious fashion, cellular injury may
More informationOrthostatic Hypotension Following Spinal Cord Injury
Orthostatic Hypotension Following Spinal Cord Injury Andrei Krassioukov, MD, PhD, FRCPC Jill Maria Wecht, EdD Robert W Teasell, MD, FRCPC Janice J Eng, PhD, BSc (PT/OT) www.scireproject.com Version 5.0
More informationNeurally mediated syncope (NMS) is a common clinical
Serotonin Reuptake Inhibitor (Paxil) Does Not Prevent the Vasovagal Reaction Associated With Carotid Sinus Massage and/or Lower Body Negative Pressure in Healthy Volunteers Theodore S. Takata, MD; Stephen
More informationSyncope as we age: Frequency of causes and cost of care
Syncope as we age: Frequency of causes and cost of care Dr Steve W Parry Clinical Senior Lecturer and Honorary Consultant Physician Clinical Director, Medicine Falls and Syncope Service, Royal Victoria
More informationManaging falls in the elderly: real world approach DR PRISCILLA NG
Managing falls in the elderly: real world approach DR PRISCILLA NG A fall is defined as an event which results in a person coming to rest inadvertently on the ground or floor or other lower level. FALL:
More information